We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$146M
AUM Growth
–
Cap. Flow
+$152M
Cap. Flow %
103.84%
Top 10 Hldgs %
99.92%
Holding
11
New
11
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$126M
2
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$6.93M
3
ARCT icon
Arcturus Therapeutics
ARCT
+$4.11M
4
SQNM
SEQUENOM INC NEW
SQNM
+$3.71M
5
CELG
Celgene Corp
CELG
+$3.36M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 9.51%
2 Financials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDVN
1
DELISTED
MEDIVATION, INC.
MDVN
$123M 84.26%
+5,008,202
New +$126M
AMPE
2
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$7.55M 5.16%
+4,362
New +$6.93M
ARCT icon
3
Arcturus Therapeutics
ARCT
$157M
$4.02M 2.75%
+83,857
New +$4.11M
SQNM
4
DELISTED
SEQUENOM INC NEW
SQNM
$3.91M 2.67%
+928,100
New +$3.71M
GNW icon
5
Genworth Financial
GNW
$3.8B
$3.65M 2.5%
+320,000
New +$3.33M
VVUS
6
CALL
DELISTED
Vivus Inc
VVUS
$1.43M 0.98%
+500
New +$64.5K
LUMO
7
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$935K 0.64%
+5,271
New +$746K
KERX
8
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$747K 0.51%
+100,000
New +$781K
ACHN
9
DELISTED
Achillion Pharmaceuticals
ACHN
$450K 0.31%
+55,000
New +$420K
CELG
10
DELISTED
Celgene Corp
CELG
$204K 0.14%
+55,850
New +$3.36M
ECTE
11
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$111K 0.08%
+444,445
New +$2.33M

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Knoll Capital Management, which disclosed 11 positions worth $146M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is MEDIVATION, INC.: 5,008,202 shares worth $123M.

By sector, the portfolio is most concentrated in Healthcare at 9.5% of assets, followed by Financials.

  • Knoll Capital Management's largest Q2 2013 buy was MEDIVATION, INC.: 5,008,202 shares worth $123M.
  • Knoll Capital Management's ten largest holdings make up 100% of its $146M portfolio in Q2 2013.
  • Knoll Capital Management disclosed 11 positions in Q2 2013, its first 13F filing on record.

Based on Knoll Capital Management's 13F filing for Q2 2013, filed 15 Aug 2013.